-S M Alam Researcher Activity Profile

Research Author Detailed Information 

S M Alam Publication Rate By Year

S M Alam has published 1 paper(s) in 1987, 2 paper(s) in 1988, 3 paper(s) in 1989, 6 paper(s) in 1991, 1 paper(s) in 1992, 1 paper(s) in 1993, 1 paper(s) in 2002, 3 paper(s) in 2006, 12 paper(s) in 2007, 5 paper(s) in 2008, for a total of 35 research publications in total.

S M Sm Alam Author Information

LAST NAME: alam

FIRST NAME: S M

INITIALS: sm

AFFILIATION:

Papers

S M Alam's Publication Record

1. Effects of drugs against cytotoxic compoundsfrom marine animals iv-hepatotoxic activity ofsea-snake hydrophis cyanocinctus venom. Year Published: 2006
Department of Biochemistry and M.A.H.Q. Biological Research Centre, University of Karachi, Karachi-75270, Pakistan.
2. Detection of Ebola virus envelope using monoclonal and polyclonal antibodies in ELISA, surface plasmon resonance and a quartz crystal microbalance immunosensor. Year Published: 2006
Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, United States. yu000022@mc.duke.edu
3. A uterine decidual cell cytokine ensures pregnancy-dependent adaptations to a physiological stressor. Year Published: 2006
Department of Pathology and Laboratory Medicine, Institute of Maternal-Fetal Biology, Division of Cancer and Developmental Biology, University of Kansas Medical Center, Kansas City, KS 66160, USA.
4. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. Year Published: 2007
Department of Medicine, Duke Human Vaccine Institute, Duke University School of Medicine, RP1 Circuit Drive, Durham, NC 27710, USA. alam0004@mc.duke.edu
5. The prolactin family: effectors of pregnancy-dependent adaptations. Year Published: 2007
Institute of Maternal-Fetal Biology, Division of Cancer and Developmental Biology, Department of Pathology & Laboratory of Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. msoares@kumc.edu
6. Quantitative determination of bilirubin by inhibition of chemiluminescence from lucigenin. Year Published: 2007
Department of Sensor and Display Engineering, Kyungpook National University, Taegu 702-701, Republic of Korea.
7. Role of protease activated receptor-2 in tumor advancement of ovarian cancers. Year Published: 2007
Department of Obstetrics and Gynecology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City 501-1194, Japan.
8. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity. Year Published: 2007
Department of Pathology, Box 3712, DUMC, Durham, NC 27710, USA. hfs@duke.edu
9. Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic Acid derivatives with antitumor activity in tumor-bearing mice. Year Published: 2007
Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University.
10. Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic Acid derivatives with antitumor activity in tumor-bearing mice. Year Published: 2007
Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.
11. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. Year Published: 2007
Human Vaccine Institute, Box 3258, Duke University Medical Center, MSRBII Bldg., Room 4042, Durham, NC 27710, USA. alam0004@mc.duke.edu
12. Role of protease activated receptor-2 in tumor advancement of ovarian cancers. Year Published: 2007
Department of Obstetrics and Gynecology, Gifu University School of Medicine, 1-1 Yanagido, Gifu City 501-1194, Japan.
13. Chemoimmunotherapeutic approach to prolonged survival time in combination with immunization and glutamic Acid derivatives with antitumor activity in tumor-bearing mice. Year Published: 2007
Division of Medicinal and Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India.
14. Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. Year Published: 2007
Human Vaccine Institute, Box 3258, Duke University Medical Center, MSRBII Bldg., Room 4042, Durham, NC 27710, USA. alam0004@mc.duke.edu
15. HIV-1 Hides an Achilles' Heel in Virion Lipids. Year Published: 2008
Duke Human Vaccine Institute, Departments of Medicine, Pathology, and Immunology, Duke University School of Medicine, Durham, NC 27710, USA.
16. Quantitative determination of bilirubin by inhibition of chemiluminescence from lucigenin. Year Published: 2007
Department of Sensor and Display Engineering, Kyungpook National University, Taegu 702-701, Republic of Korea.
17. Cancer patterns in Karachi division (1998-1999). Year Published: 2002
Department of Pathology, Sindh Medical College, Karachi.
18. Eosinophilic gastritis. Year Published: 1987
19. A histopathological study of analgesic hepatotoxicity in rabbit. Year Published: 1988
20. An experimental study of analgesic nephropathy in rabbit. A light microscopic study. Year Published: 1988
21. Potentiating effects of phenobarbitone on the induction of cirrhosis in rats by carbon tetrachloride. Year Published: 1989
22. Histopathological study of endoscopic biopsies of stomach. Year Published: 1989
23. A review of the unusual liver tumours. Year Published: 1989
24. Association of Helicobacter pylori with acid peptic disease in Karachi. Year Published: 1991
Department of Pathology, Basic Medical Sciences Institute, Karachi.
25. A placebo controlled trial of bismuth salicylate in Helicobacter pylori associated gastritis. Year Published: 1991
Department of Pathology, Pakistan Medical Research Council, Karachi.
26. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease. Year Published: 1991
Department of Pathology, Jinnah Postgraduate Medical Centre, Karachi.
27. Correlation of endoscopic and histological diagnosis in upper gastrointestinal lesions. Year Published: 1991
Department of Pathology, Jinnah Post graduate Medical Centre, Karachi.
28. Testicular tumours: histology, prevalence and epidemiology. Year Published: 1991
Department of Pathology, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, Karachi.
29. Giardia lamblia in patients undergoing upper G.I. endoscopy. Year Published: 1991
Department of Pathology, Jinnah Postgraduate Medical Centre, Karachi.
30. Oesophageal carcinoma in Karachi. Year Published: 1992
PMRC Research Centre, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, Karachi.
31. Characterization of Reed-Sternberg cells with granulocyte specific monoclonal antibody. Year Published: 1993
Department of Pathology, Jinnah Postgraduate Medical Centre, Karachi.
32. HIV-1 hides an Achilles' heel in virion lipids. Year Published: 2008
Duke Human Vaccine Institute, Departments of Medicine, Pathology, and Immunology, Duke University School of Medicine, Durham, NC 27710, USA. hayne002@mc.duke.edu <hayne002@mc.duke.edu>
33. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Year Published: 2008
1Department of Obstetrics and Gynecology, Gifu University School of Medicine, Yanagido 1-1, Gifu City 501-1194, Japan.
34. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers. Year Published: 2008
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Yanagido 1-1, Gifu City 501-1194, Japan.
35. Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopes' Accessibility. Year Published: 2008
Department of Chemistry, University of Kansas, Lawrence, Kansas 66045, Duke Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina 22710 hdesaire@ku.edu.